Jen-Pang Wang

ORCID: 0000-0001-6523-1799
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Schizophrenia research and treatment
  • Diet and metabolism studies
  • Genetic Associations and Epidemiology
  • Microwave Dielectric Ceramics Synthesis
  • Bioinformatics and Genomic Networks
  • Mental Health and Psychiatry
  • Advanced ceramic materials synthesis
  • Epilepsy research and treatment
  • Bipolar Disorder and Treatment
  • Mental Health Treatment and Access
  • High-Temperature Coating Behaviors
  • Epigenetics and DNA Methylation
  • BRCA gene mutations in cancer
  • Child and Adolescent Psychosocial and Emotional Development
  • Genetics and Neurodevelopmental Disorders

Neuropsychiatric Research Institute
2025

National Health Research Institutes
2025

Bali Psychiatric Center
2024

National Taiwan University
2019-2020

<title>Abstract</title> BACKGROUND Despite a high heritability of schizophrenia (SZ), only limited variance was attributed to gene loci or the polygenic risk score in genome-wide association studies (GWAS). Early-onset SZ, more homogeneous SZ subtype, may aid bridging genotype-phenotype gap and identification its hub genes is critical for early intervention clinical practice. We aimed examine expression (GeRS) patients from both multiplex simplex families identify early-onset perform...

10.21203/rs.3.rs-5833160/v1 preprint EN 2025-01-20

Thankfulness and Responsibility I am thankful for the support from members board of directors Taiwanese Society Psychiatry (TSOP). It is my honor to be 32nd president TSOP. As a practitioner in psychiatric clinics improved past nine years, position reflects consistency 25-year career as psychiatrist, acts bridge between different systems internationally, promotes collaboration clinical, educational, research, government, community mental health institutions. According report Medical...

10.4103/tpsy.tpsy_2_24 article EN cc-by-nc-sa Taiwanese Journal of Psychiatry 2024-01-01

Abstract Background Switching to aripiprazole from other antipsychotics can avoid antipsychotic-induced hyperprolactinemia but may result in an abnormally low prolactin level. This study aimed assess whether the aripiprazole-induced level was a biomarker for subsequent rebound of positive symptoms schizophrenia patients. Methods Participants were 63 patients 8-week trial switching aripiprazole, which preswitching maintained first 2 weeks and fixed at 15 mg orally throughout trial. A &lt; 3.7...

10.1186/s12888-020-02957-7 article EN cc-by BMC Psychiatry 2020-11-23

Abstract Background Examining patients with first-episode psychosis (FEP) provides opportunities to better understand the mechanism underlying these illnesses. By incorporating quantitative measures in FEP patients, we aimed (1) determine baseline distribution of clinical features; (2) examine impairment magnitude by comparing external controls and then counterparts schizophrenia different familial loadings; (3) evaluate whether were associated features. Methods Patients recruited from one...

10.1186/s12888-024-05598-2 article EN cc-by BMC Psychiatry 2024-02-22
Coming Soon ...